Home > What we do > Medicine & Healthcare > hMedicine > hMedicine Story

Chinese Delegation Visits Hadassah's Hospital on First Trip to Israel

A delegation of Chinese health officials visited Hadassah Medical Organization.

A delegation of Chinese health officials, led by Professor Xiaochun Chen, Deputy Director-General of the Provincial Department of Health of Hunan Province, which has more than 75 million citizens, visited Hadassah Medical Organization at Ein Kerem on Sunday.

On their first trip to Israel, the doctors and administrators asked to see the hospital, and to gain insight into Israel's medical achievements.

Professor Chen completed medical school in Beijing and later graduated from Johns Hopkins Medical Center's School for Public Health. He was particularly interested in the vision of Baltimorean Henrietta Szold, and the connection between American Jewry and the Israel medical center.

They visited the Pediatric Intensive Care Unit and met with Dr. Philip Toltzis who heads the unit about medical care for Jews and Palestinians, and toured the healing gardens and Orthopedic unit of the Sarah Wetsman Davidson Tower.

The visit to the Abbell Synagogue with its Chagall Windows was the first time they had ever been in a synagogue. One of the visiting physicians heads a hospital with over 4000 beds. Another was an obstetrician who was interested in the large number of babies which many Jerusalem women have in contrast to their Chinese contemporaries. The visitors heard about Hadassah's advances in genetics and the special challenges of Hadassah's unique blend of modern medicine and traditional patients.

Date: 7/1/2013


More hMedicine Stories




Hadasit, Hadassah’s Technology Transfer Arm, Reviews 2012’s Accomplishments

When the Hadassah University Medical Center’s physicians suggest a solution to a medical problem which can lead to the development of a new medicine or product, Hadasit, Hadassah’s technology transfer arm, explores its feasibility and supports the promotion of those viable ideas with innovation potential. Although 2012 has been “a year full of challenges for the life science industry,” says Einat Zisman, Hadasit’s Chief Executive Officer, Hadasit still signed 125 agreements for clinical trials, all to be done at Hadassah. In addition, Hadasit signed 15 agreements for cooperation and commercialization of technologies that were developed at Hadassah. Click here to read the latest Newsletter from Hadasit >>

   |  Who We Are  |  What We Do  |  Where We Do It  |  Read About It  |  Join Now  |  Donate  |
  |  Login  |  Contact Us  |  Careers  |  Terms & Conditions  |  
Copyright ©2014 Hadassah is a registered trademark of Hadassah, the Women's Zionist Organization of America